Relationship between Dialysate Bicarbonate Concentration and All-Cause Mortality in Hemodialysis Patients.
血液透析患者中透析液碳酸氫根濃度與全因死亡率之關係。
Kidney Blood Press Res 2024-04-12
Associations of calcium, phosphate and intact parathyroid hormone levels with mortality, residual kidney function and technical failure among patients on peritoneal dialysis.
透析患者中鈣、磷和完整甲狀旁腺素水平與死亡率、殘餘腎功能和技術失敗的關聯。
Clin Kidney J 2023-11-03
A Metabolomics Approach to Identify Metabolites Associated With Mortality in Patients Receiving Maintenance Hemodialysis.
一種代謝組學方法以識別與接受維持性血液透析患者死亡率相關的代謝物。
Kidney Int Rep 2024-09-18
Associations of abnormal fluid status, plasma sodium disorders, and low dialysate sodium with mortality in hemodialysis patients.
異常液體狀態、血漿鈉異常及低透析液鈉與血液透析患者死亡率的關聯。
Clin J Am Soc Nephrol 2024-09-18
The effects of dialysate calcium prescription on mortality outcomes in incident patients on hemodialysis.
透析液鈣處方對新發血液透析患者死亡結果的影響。
Clin Kidney J 2024-10-11
這項研究探討不同透析液鈣濃度(1.25 vs. 1.50 mmol/l)對成人血液透析患者死亡率的影響,共納入12,897名使用1.25 mmol/l和26,989名使用1.50 mmol/l的患者,平均年齡65歲,61%為男性。初步分析顯示1.50 mmol/l組的全因死亡風險較高,但調整後並無顯著差異,且1.50 mmol/l組的猝死風險反而較低。此外,血清與透析液鈣濃度的差異與結果相關。總體來看,調整後的數據顯示死亡率無顯著差異,且可能對猝死風險有益。
PubMedDOI
Associations of Abnormal Fluid Status, Plasma Sodium Disorders, and Low Dialysate Sodium with Mortality in Patients on Hemodialysis.
異常液體狀態、血漿鈉異常及低透析液鈉與血液透析患者死亡率的關聯。
Clin J Am Soc Nephrol 2024-11-18